Villena v. Iancu (Supreme Court Dkt. No. 18-1223), which is the 43rd patent eligibility case to be considered for certiorari since the notorious Alice Corp. decision, was denied cert. on June 10. Villena would have been the 45th patent eligibility case to be considered for certiorari, but the Supreme Court kicked the can over to the Solicitor General for both Vanda Pharmaceuticals and Berkheimer, which happen to be Alice/Mayo cases in which the Federal Circuit held the inventions at issue to be patent eligible. That’s no coincidence. The rough probability of waiting through 43 petitions outlining the capricious decisions from the lower courts before the Supreme Court might generate a “yes” to certiorari is well-above one standard deviation and approaching two standard deviations. It is beyond evident that the Supreme Court refuses to clean up its own mess and will continue to do so for the indefinite future.
Recent Posts
- CAFC Affirms Obviousness of Vehicle ID Claims, Finds Substitute Claims Ineligible Under Section 101
- U.S. Patent Litigation Trends in 2025: Patterns Behind the Numbers
- Other Barks & Bites for Friday, September 26: Trump Announces 100% Tariff on Patented Pharmaceuticals; Judge Alsup Approves $1.5 Billion Anthropic AI Settlement; and DOJ Weaponization Group Reportedly Investigating Secret Patent Reviews
- CAFC Vacates TTAB Decision Over Inconsistent Application of DuPont Factors
- Squires Signs First Patents, Signals Commitment to Keep Emerging Technologies Eligible
